Angiotensinogen
| GO Term | Evidence Code | Reference |
|---|---|---|
| ovarian follicle rupture | ||
| blood vessel development | ||
| branching involved in ureteric bud morphogenesis | ||
| branching involved in ureteric bud morphogenesis | ||
| positive regulation of cytokine production |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region |
| GO Term | Evidence Code | Reference |
|---|---|---|
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity | ||
| hormone activity | ||
| growth factor activity | ||
| sodium channel regulator activity |
| Pathway Name | Organism |
|---|---|
| G alpha (i) signalling events | Mus musculus |
| G alpha (q) signalling events | Mus musculus |
| Metabolism of Angiotensinogen to Angiotensins | Mus musculus |
| Peptide ligand-binding receptors | Mus musculus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026